Restructuring and Other Costs (Tables)

9 Months Ended

Oct. 01, 2022

Restructuring and Related Activities [Abstract]

Schedule of Restructuring and Other Costs by Segment

Restructuring and other costs by segment are as follows:

	Three months ended		Nine months ended
(In millions)	October 1, 2022		October 1, 2022
Life Sciences Solutions	$	5	$	11
Analytical Instruments	2		6
Specialty Diagnostics	19		22
Laboratory Products and Biopharma Services	7		20
	$	33	$	59

Summary of Changes in the Company's Accrued Restructuring Balance

The following table summarizes the changes in the company’s accrued restructuring balance, which is included in other accrued expenses in the accompanying balance sheet. Other amounts reported as restructuring and other costs in the accompanying statement of income have been summarized in the notes to the table.

(In millions)	Total (a)
Balance at December 31, 2021	$	17
Net restructuring charges incurred in 2022 (b)	31
Payments	(30)
Currency translation	(1)
Balance at October 1, 2022	$	17

(a)The movements in the restructuring liability principally consist of severance and other costs such as relocation and moving expenses associated with facility consolidations, as well as employee retention costs which are accrued ratably over the period through which employees must work to qualify for a payment.

(b)Excludes $28 million of net non-cash charges, primarily charges for impairment of long-lived assets.